New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications

Pediatric Transplantation

Volumn 17, Issue 4, 2013, Pages 328-335

  Telega, Grzegorz ^a,b   Cronin, David ^a   Avner, Ellis D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE   (United States)

Author keywords

ascending cholangitis; autosomal recessive polycystic kidney disease; Caroli disease syndrome; congenital hepatic fibrosis; end stage renal disease; kidney transplant; liver transplant; portal hypertension

Indexed keywords

ANTIBIOTIC AGENT; URSODEOXYCHOLIC ACID;

AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE; BILE DUCT CARCINOMA; CAROLI DISEASE; CHILDHOOD DISEASE; CHOLANGITIS; CHOLESTASIS; CLINICAL DECISION MAKING; DISEASE ASSOCIATION; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HEPATOBILIARY DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISOLATED KIDNEY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MORBIDITY; PORTAL HYPERTENSION; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SURGICAL MORTALITY; SURVIVAL RATE;

EID: 84878011665     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12076     Document Type: Review

References (41)

1. Gunay-Aygun M, Avner ED, Bacallao RL, et al. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr 2006: 149: 159-164.
2. Roy S, Dillin MJ, Trompeter RS, Barratt TM,. Autosomal recessive polycystic kidney disease: Long-term outcome of neonatal survivors. Pediatr Nephrol 1997: 11: 302-306.
3. Adeva M, El-Youssef M, Rosetti S, et al. Clinical and molecular characterisations defines a broadened spectrum of autosomal recessive polycystic disease (ARPKD). Medicine 2006: 85: 1-21.
4. Blyth H, Ockenden BG,. Polycystic disease of kidney and liver presenting in childhood. J Med Genet 1971: 8: 257-284.
5. Turkbey B, Ocak I, Daryanani K, et al. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF). Pediatr Radiol 2009: 39: 100-111.
6. Davis ID, Ho M, Hupertz V, Avner ED,. Survival of childhood polycystic kidney disease following renal transplantation: The impact of advanced hepatobiliary disease. 2003: 7: 364-369.
7. Khan K, Schwarzenberg SJ, Sharp HL, Matas AJ, Chavers BM,. Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. Am J Transplant 2002: 2: 360-365.
8. McDiarmid SV, Anand R, Martz K, Millis MJ, Mazariegos G,. Multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver 3. Ann Surg 2011: 254: 145-154.
9. Bucuvalas J,. Long-term outcomes in pediatric liver transplantation. Liver Transpl 2009: 15 (Suppl 2): S6-S11.
10. Nakanishi K, Sweeney WE Jr, Zerres K, Guay-Woodford LM, Avner ED,. Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease. J Am Soc Nephrol 2000: 11: 760-763.
11. Zerres K, Mucher G, Becker J, et al. Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 1998: 76: 137-144.
12. Dell KM, Avner ED,. Autosomal Recessive Polycystic Kidney Disease: GeneClinics: Clinical Genetic Information Resource [database online] Copyright. Seattle: University of Washington, Available at http://wwwgeneclinicsorg. Initial posting July 2001 updated July 2011.
13. Dell KM, Sweeney WE, Avner ED,. Polycystic kidney disease. In:, Avner ED, Harmon WE, Niaudet P, eds. Pediatric Nephrology, 6th edn. Berlin, Heidelberg: Springer-Verlag, 2009: 849-887.
14. Kamath BM, Piccoli DA,. Heritable disorders of the bile ducts. Gastroenterol Clin North Am 2003: 32: 857-875.
15. Bergmann C, Frank V, Kupper F, et al. Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease. Mol Diagn Ther. 2006: 10: 163-174.
16. Schneider BL, Magid MS,. Liver disease in autosomal recessive polycystic kidney disease. Pediatr Transpl 2005: 9: 634-639.
17. Zerres K, Rudnik-Schoneborn S, Deget F, et al. Autosomal recessive polycystic kidney disease. J Mol Med 1998: 76: 303-309.
18. Wen J,. Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease. Clin Transl Sci 2011: 4: 460-465.
19. Sweeney WE Jr, Avner ED,. Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol 2011: 26: 675-692.
20. Chapal M, Deboot A, Dufay A, et al. Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: A multicentric study. Nephrol Dial Transpl 2012: 27: 2083-2088.
21. Guay-Woodford LM, Desmond RA,. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis. Pediatrics 2003: 111: 1072-1080.
22. Srinath A, Shneider BL,. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr 2012: 54: 580-587.
23. Fox VL, Carr-Locke DL, Connors PJ, Leichtner A,. Endoscopic ligation of esophageal varices in children. J Pediatr Gastroenterol Nutr 1995: 20: 202-208.
24. Reinoso MA, Sharp HL, Rank J,. Endoscopic variceal ligation in pediatric patients with portal hypertension secondary to liver cirrhosis. Gastrointest Endosc 1997: 46: 244-246.
25. Shneider BL, Bosch J, De Franchis R, et al. Portal Hypertension in Children: Expert pediatric opinion on the report of Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transpl 2012: 16: 426-437.
26. Hou MC, Lin HC, Kuo BIT,. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial. Hepatology 1995: 21: 1517-1522.
27. Zargar SA, Javid G, Khan BA, et al. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology 2002: 36: 666-672.
28. Schreiber RA,. Propranolol and portal hypertension: Should kids be on the block? J Pediatr Gastroenterol Nutr 1999: 29: 10-11.
29. Imperiale TF, Chalasani N,. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001: 33: 802-807.
30. Celińska-Cedro D, Teisseyre M, Woynarowski M, Socha P, Socha J, Ryzko J,. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: Preliminary results of a prospective study. J Pediatr Surg 2003: 38: 1008-1011.
31. Rivet C, Robles-Medranda C, Dumortier J, Le Gall C, Ponchon T, Lachaux A,. Endoscopic treatment of gastroesophageal varices in young infants with cyanoacrylate glue: A pilot study. Gastrointest Endosc 2009: 69: 1034-1038.
32. Kisewetter WB, Patrick DB,. Childhood splenectomy: Indications for and results from. Am Surg 1971: 37: 135-139.
33. Alkhouri N, Carter-Kent C, Mayacy S, et al. Reversal of protein-losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis. Liver Transpl 2009: 15: 1894-1896.
34. Tsimaratos M, Cloarec S, Roquelaure B, et al. Chronic renal failure and portal hypertension-is portosystemic shunt indicated? Pediatr Nephrol 2000: 14: 856-858.
35. Dhalluin-Venier V, Fabre M, Jacquemin E, Rangheard A-S, Pelletier G, Buffet C,. Liver cell adenomas and portosystemic shunt. Gastroenterol Clin Biol 2008: 32: 164-166.
36. Jain D, Nayak NC, Saigal S,. Hepatocellular carcinoma arising in association with von-Meyenburg's complexes: An incidental finding or precursor lesions? A clinicopathologic study of four cases. Ann Diagn Pathol 2010: 14: 317-320.
37. Barshes NR, Lee TC, Udell IW, et al. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl 2006: 12: 475-480.
38. Ko J, Yi NJ, Suh KS, Seo JK,. Pediatric liver transplantation for fibrocystic liver disease. Pediatr Transpl 2012: 16: 195-200.
39. Baan CC, Weimar W,. How does auxiliary liver transplantation regulate alloreactivity in sensitized kidney transplant patients? Transplantation 2011: 91: 823-824.
40. Chava SP, Singh B, Stangou A, et al. Simultaneous combined liver and kidney transplantation: A single center experience. Clinic Transpl 2010: 24: E62-E68.
41. Sweeney WE Jr, Von Vigier RO, Frost P, Avner ED,. Src inhibition ameliorates polycystic kidney disease. J Am Soc Nephrol 2008: 7: 1331-1341.